Publicaciones en las que colabora con José Ignacio López Villalba (58)

2024

  1. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Fibroblast Activation Protein-α (FAP) Identifies Stromal Invasion in Colorectal Neoplasia

    The American journal of surgical pathology, Vol. 47, Núm. 9, pp. 1027-1033

2021

  1. (Pro)renin receptor is a novel independent prognostic marker in invasive urothelial carcinoma of the bladder

    Cancers, Vol. 13, Núm. 22

  2. Clinical implications of (Pro)renin receptor (prr) expression in renal tumours

    Diagnostics, Vol. 11, Núm. 2

  3. Protein Tyrosine Phosphatases in Neuroblastoma: Emerging Roles as Biomarkers and Therapeutic Targets

    Frontiers in Cell and Developmental Biology, Vol. 9

  4. SARS-CoV-2-associated obliterative arteritis causing massive testicular infarction

    Clinics and Practice, Vol. 11, Núm. 2, pp. 246-249

  5. Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma

    Cancers, Vol. 13, Núm. 4, pp. 1-17

2020

  1. Altered tissue and plasma levels of fibroblast activation protein-α (FAP) in renal tumours

    Cancers, Vol. 12, Núm. 11, pp. 1-16

2019

  1. Dual-specificity phosphatases in neuroblastoma cell growth and differentiation

    International Journal of Molecular Sciences, Vol. 20, Núm. 5

  2. Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology

    npj Precision Oncology, Vol. 3, Núm. 1

  3. Precise immunodetection of PTEN protein in human neoplasia

    Cold Spring Harbor Perspectives in Medicine, Vol. 9, Núm. 12

  4. Protein tyrosine phosphatase PTPN1 modulates cell growth and associates with poor outcome in human neuroblastoma

    Diagnostic Pathology, Vol. 14, Núm. 1

2018

  1. DUSP5 expression associates with poor prognosis in human neuroblastoma

    Experimental and Molecular Pathology, Vol. 105, Núm. 3, pp. 272-278

2017

  1. Expression and activity of angiotensin-regulating enzymes is associated with prognostic outcome in clear cell renal cell carcinoma patients

    PLoS ONE, Vol. 12, Núm. 8

  2. The relevance of precision epitope mapping for accurate oncologic diagnostic based on PTEN protein expression in tumours

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28

2016

  1. Low-grade metastases in high-grade clear cell renal cell carcinomas A clinicopathologic study of 4 cases with an insight into the role of mesenchymal-to-epithelial transition process

    Annals of Diagnostic Pathology, Vol. 20, pp. 13-18

2015

  1. Large (>3.8 cm) clear cell renal cell carcinomas are morphologically and immunohistochemically heterogeneous

    Virchows Archiv, Vol. 466, Núm. 1, pp. 61-66

2013

  1. Altered peptidase activities in thyroid neoplasia and hyperplasia

    Disease Markers, Vol. 35, Núm. 6, pp. 825-832

  2. Clinical impact of aspartyl aminopeptidase expression and activity in colorectal cancer

    Translational Research, Vol. 162, Núm. 5, pp. 297-308

2008

  1. El adenocarcinoma de próstata en los años 1999 y 2006. Diferencias en el estudio comparativo de biopsias transrectales y de prostatectomías radicales

    Revista Espanola de Patologia, Vol. 41, Núm. 2, pp. 117-121